Free Trial

Amicus Therapeutics (FOLD) Insider Trading & Ownership

Amicus Therapeutics logo
$9.59 +0.07 (+0.74%)
(As of 11/20/2024 ET)

Amicus Therapeutics (NASDAQ:FOLD) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
2.20%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
7
Amount Of
Insider Selling
(Last 12 Months)
$4.53 M
Get FOLD Insider Trade Alerts

Want to know when executives and insiders are buying or selling Amicus Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

FOLD Insider Buying and Selling by Quarter

Amicus Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/6/2024Bradley L CampbellCEOSell7,901$12.50$98,762.50  
11/1/2024Bradley L CampbellCEOSell7,500$11.46$85,950.00  
10/1/2024Bradley L CampbellCEOSell7,500$10.60$79,500.00  
9/3/2024Bradley L CampbellCEOSell7,500$11.71$87,825.00  
8/1/2024Bradley L CampbellCEOSell7,500$10.34$77,550.00  
7/5/2024Bradley L CampbellCEOSell6,100$10.00$61,000.00  
5/1/2024Bradley L CampbellCEOSell7,500$10.07$75,525.00  
3/5/2024Margaret G McglynnDirectorSell7,500$13.40$100,500.00  
2/15/2024Bradley L CampbellCEOSell4,167$14.00$58,338.00  
2/15/2024David Michael ClarkInsiderSell4,427$14.00$61,978.00  
2/15/2024John F CrowleyChairmanSell31,614$13.81$436,589.34  
2/6/2024Ellen RosenbergInsiderSell400$13.00$5,200.00  
1/22/2024John F CrowleyChairmanSell55,327$12.36$683,841.72  
1/16/2024John F CrowleyChairmanSell31,614$12.78$404,026.92  
1/10/2024John F CrowleyChairmanSell31,614$13.65$431,531.10  
1/9/2024David Michael ClarkInsiderSell1,384$14.00$19,376.00  
1/8/2024Samantha ProutCAOSell30,767$14.00$430,738.00  
1/2/2024Bradley L CampbellCEOSell15,833$14.23$225,303.59  
1/2/2024Ellen RosenbergInsiderSell30,000$14.21$426,300.00  
12/27/2023Ellen RosenbergInsiderSell5,000$14.07$70,350.00  
12/26/2023Samantha ProutCAOSell7,659$14.00$107,226.00  
12/19/2023Jeff CastelliInsiderSell17,500$13.25$231,875.00  
12/15/2023John F CrowleyChairmanSell6,043$12.66$76,504.38  
12/1/2023Bradley L CampbellCEOSell11,702$11.08$129,658.16  
12/1/2023John F CrowleyChairmanSell6,043$11.08$66,956.44  
(Data available from 1/1/2013 forward)

FOLD Insider Trading Activity - Frequently Asked Questions

The list of insiders at Amicus Therapeutics includes Bradley L Campbell, Daphne Quimi, David Michael Clark, Ellen Rosenberg, Jeff Castelli, John F Crowley, Margaret G Mcglynn, Michael Raab, and Samantha Prout. Learn more on insiders at FOLD.

2.20% of Amicus Therapeutics stock is owned by insiders. Learn more on FOLD's insider holdings.

The following insiders have sold FOLD shares in the last 24 months: Bradley L Campbell ($2,870,654.46), Daphne Quimi ($62,450.00), David Michael Clark ($538,469.88), Ellen Rosenberg ($925,945.48), Jeff Castelli ($231,875.00), John F Crowley ($6,576,283.60), Margaret G Mcglynn ($295,950.00), Michael Raab ($49,942.64), and Samantha Prout ($1,055,059.09).

Insiders have sold a total of 998,935 Amicus Therapeutics shares in the last 24 months for a total of $12,606,630.15 sold.

Amicus Therapeutics Key Executives



This page (NASDAQ:FOLD) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners